|
(FLASH study)A 12-week treatment, multi-center, randomized, doubleblind,double-dummy, parallel group study to assess the efficacy and safety of switching fromsalmeterol/fluticasone to QVA149 (indacaterolmaleate/glycopyrronium bromide) in symptomatic COPD patients
|
Ongoing
|
Ultibro breezhaler
|
4
|
A3405 V01
|
King Fahad Medical City (Riyadh), King Fahad University Hospital (Al-Khobar), King Abdulaziz Medical City NG (Jeddah)
|
|
XALIA LEA- Xarelto® for Long-term and Initial Anticoagulation in VenousThromboembolism (VTE) in Latin America,EMEA and Asia
|
Ongoing
|
Rivaroxaban
|
4
|
17237
|
King Fahad Medical City (Riyadh), King Fahad Hospital (Madinah), King Faisal Hospital (Taif), Hira Hospital (Makkah)
|
|
Prospective Multicentre Observational Registry Of Treatments And Outcomes In Patients With Chronic
|
Ongoing
|
N/A
|
4
|
ONC-MA1002
|
Aseer Central Hospital
|
|
Early Goal Directed Sedation vs. Standard Care Sedation
|
Ongoing
|
Dexmedetomidine
|
4
|
YS/003
|
King Saud Medical City (Riyadh)
|
|
Efficacy of Different Mouthwashes in the Reduction of Halitosis: A Randomized, Double Blind, Placebo-Controlled, Crossover Clinical Trial
|
Ongoing
|
Halita - AO ProRinse
|
4
|
PR oo39
|
College of Dentistry King Saud University
|
|
easypod connect: A regional, Multicentre, Observational study to evaluate Adherenceand Long Term Outcomes of Therapy in Paediatric subjects using “easypodTM” electromechanical device for growth hormone treatment
|
Ongoing
|
N/A
|
4
|
EMR200104-534
|
King Fahad University Hospital (Al-Khobar), alhabib
|
|
Observational Prospective STudy In Management of 1st line KRAS Wildtype mCRC with Erbitux™ (Cetuximab)- OPTIM1SE
|
Ongoing
|
Erbitux (Cetuximab)
|
4
|
EMR062202-561
|
King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Riyadh), Prince Sultan Military Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
|
|
Postoperative Analgesic Effect ofDexmedetomidine as an Adjunct to Ropivacaine Administration in Wound Infiltration for Modified Radical Mastectomy- A Randomized controlled Trial
|
Ongoing
|
DEXMEDETOMIDINE
|
2
|
14-119
|
King Abdullah Medical City (Makkah)
|
|
AWARE-AMAC (A World-wide Antihistamine-Refractory chronic urticaria patient Evaluation in Asia pacific, Middle-east and African Countries (AWARE-AMAC): A noninterventional study to collect data on the management and clinical impacts of chronic urticaria in patients refractory to H1-antihistamine therapy
|
Ongoing
|
N/A
|
4
|
E3401
|
King Abdulaziz University Hospital (Jeddah), King Fahad Specialist Hospital (Dammam), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)
|
|
Non transfusion dependent Thalassemia Drug Registry
|
Ongoing
|
Exjade (Deferasirox)
|
4
|
E2422
|
King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Jeddah), King Khalid University Hospital (Riyadh)
|
